Proposed Registration Decision PRD2020-15, Trifludimoxazin, Vulcarus and Voraxor
This summary describes the key points of the evaluation, while the Science Evaluation of Proposed Registration Decision PRD2020-15, Trifludimoxazin, Vulcarus and Voraxor provides detailed technical information on the human health, environmental and value assessments of trifludimoxazin, Vulcarus and Voraxor.
- Publisher
- Health Canada
- Resources
- 2
- Catalogue metadata updated
- 2023-03-29
Data overview
- Formats
- HTML
- File languages
- English, French